Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib
Francine M. Foss, Ami N. Rubinowitz, Marie L. Landry, Iris Isufi, Lohith Gowda, Stuart Seropian, Sarah Perreault, Sheela Shenoi
Topics & Concepts
RuxolitinibMedicineHematopoietic stem cell transplantationPneumoniaCoronavirusStem cellTransplantationCoronavirus disease 2019 (COVID-19)ImmunologyHaematopoiesisViral pneumoniaRespiratory systemVirologyInternal medicineBiologyBone marrowDiseaseInfectious disease (medical specialty)MyelofibrosisGeneticsPhagocytosis and Immune RegulationChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia Treatments